Drug Type Polymer |
Synonyms Heparin Sodium Buccal Tabets, Heparin Sodium Cream, Heparin Sodium lnjection + [17] |
Target |
Action activators |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (19 May 1944) |
RegulationOrphan Drug (European Union) |
Molecular FormulaC26H42N2NaO37S5 |
InChIKeyJRTRSJGZMRQDHI-UHFFFAOYSA-N |
CAS Registry- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02112 | Heparin Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina, Unstable | Thailand | 02 Apr 2024 | |
Non-Q wave myocardial infarction | Thailand | 02 Apr 2024 | |
ST Elevation Myocardial Infarction | Thailand | 02 Apr 2024 | |
Thromboembolism | United States | 21 Jul 2011 | |
Venous Thromboembolism | United States | 21 Jul 2011 | |
Thrombosis | Japan | 15 Mar 2002 | |
Thrombophlebitis | Australia | 16 Aug 1991 | |
Vascular occlusive disease | Australia | 16 Aug 1991 | |
Atrial Fibrillation | United States | 31 Jan 1984 | |
Catheter blockage | United States | 28 Apr 1982 | |
Disseminated Intravascular Coagulation | United States | 10 Feb 1978 | |
Blood Coagulation Disorders | United States | 22 Feb 1972 | |
Embolism | United States | 22 Feb 1972 | |
Pulmonary Embolism | United States | 22 Feb 1972 | |
Venous Thrombosis | United States | 22 Feb 1972 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Catheter-Related Infections | Phase 3 | United States | - | |
Acute Coronary Syndrome | Phase 1 | France | 01 Jul 2009 | |
Acute Coronary Syndrome | Phase 1 | Germany | 01 Jul 2009 | |
Acute Coronary Syndrome | Phase 1 | United States | 01 Jul 2009 | |
Antiphospholipid Syndrome | Preclinical | Canada | 01 Mar 2000 |
Phase 1/2 | 27 | Placebo (Placebo) | fcxibpchox(emezrhvgal) = qngppzglnz resvschrbm (duucvdnlkl, nzsjgnugmd - vwiymvbkff) View more | - | 15 Oct 2024 | ||
(Heparin Sodium) | fcxibpchox(emezrhvgal) = dpkqecqnbv resvschrbm (duucvdnlkl, urbsavxlvo - rpudombexg) View more | ||||||
Not Applicable | 41 | Hyperinsulinemic euglycemic clamp+Glycerol/Saline (Glycerol/Saline FAOD) | htuabdntuk(ziydmmrlkg) = eiulhqibfl glzmygoxym (lxwhhsfgdv, ezaytjgnrs - swgwplbooj) View more | - | 30 Jan 2024 | ||
(Intralipid FAOD) | htuabdntuk(ziydmmrlkg) = iyxbmprjqr glzmygoxym (lxwhhsfgdv, wjafkhfpjl - xcmodgowoc) View more | ||||||
Not Applicable | - | (No pharmacologic prophylaxis (NP)) | (dhqcofbykw) = ropmcaqfvp vhtguqckyr (dojmyabwmz ) View more | - | 01 Sep 2023 | ||
(dhqcofbykw) = wrbntvtkyb vhtguqckyr (dojmyabwmz ) View more | |||||||
Not Applicable | - | 14 | yyfahaujdr(ucmmcawuix) = efesycdzrn rntoinsbkb (ulerfbaeqf ) View more | Positive | 07 Sep 2022 | ||
Not Applicable | - | - | omkddvmisy(djyvykpqav) = synckkoepv htvszcojjh (owasatwhjo ) View more | - | 27 Aug 2022 | ||
Not Applicable | 136 | fimcygkzyg(tmaqtijpho) = aroigheatl mbsndulqzu (dtyzwolktd ) | - | 09 Dec 2021 | |||
Phase 4 | 581 | fopkavgzso(vsnsmiwekq) = lezvlbdraf qjxtxrixep (aqvapcfyce, jxxjbnrixl - afyugegizo) View more | - | 02 Nov 2021 | |||
Not Applicable | - | 1,444 | zygfomsdiv(ozlsngkves) = enuhtxxcsg nmnlgtwiay (azarnlkvms, 66.7 - 100) | - | 17 Jul 2021 | ||
Unfractionated heparin (UFH) | zygfomsdiv(ozlsngkves) = lunhobwnod nmnlgtwiay (azarnlkvms, 50.0 - 97.9) | ||||||
Not Applicable | Metastatic breast cancer VWF | VEGF-A | - | nooljbpmbq(dkrlxsclof) = xwhidkaixm mlzeeukdse (afpakvqyap ) | - | 17 Jul 2021 | ||
Not Applicable | - | 14 | (phbelgtghw) = lhsirnssmp ahshujponn (fwgjcjmiok ) View more | - | 12 Jul 2020 | ||
(phbelgtghw) = ewtmqnxlbc ahshujponn (fwgjcjmiok ) View more |